STUDIES ON A SECOND LONG-ACTING FLUPHENAZINE
Abstract
The injection of fluphenazine decanoate, a new long acting antipsychotic drug, resulted in rapid improvement in 9 of 12 chronic schizophrenic patients. The length of response following a single injection ranged from 7-39 days, with a mean length of activity of 16-22 days. This drug promises to be useful in the treatment of psychosis for economic reasons as well as its rapid action, its efficacy and its long action.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
